Sentinel lymph node biopsy (SLNB) was introduced 2 decades ago and thereafter validated
for routine surgical management of breast cancer, including cases treated with neoadjuvant …

SLN biopsy is the new standard of care for nodal staging in early-stage breast cancer
patients and contraindications are decreasing with experience. However, the clinical …

Sentinel lymph node (SLN) biopsy has been established as the standard of care for axillary
staging in patients with invasive breast carcinoma and clinically negative lymph nodes (cN …

Pathologic examination of the sentinel lymph nodes (SLNs) in patients with breast cancer
has been impacted by the publication of practicing changing trials over the last decade. With …

The aim of this narrative review was to provide an update on the use of sentinel lymph node
biopsy (SLNB) for breast carcinoma (BC). Relevant studies published between 01/01/1994 …

Axillary nodal status is an important prognostic factor in guiding locoregional and systemic
treatment for breast cancer. Sentinel lymph node biopsy (SNB) has revolutionized axillary …

Sentinel lymph node (SLN) biopsy is an exciting and promising new addition to surgical
management and pathologic evaluation of breast cancer. Sentinel nodes are more likely to …

The clinical management of breast cancer has improved tremendously in the last 2 decades.
Sentinel lymph node biopsy (SNB) allows conservation of the axillary lymph nodes in most …

Sentinel lymph node (SLN) biopsy requires validation by a backup axillary dissection in a
defined series of cases before becoming standard practice, to establish individual and …

Sentinel lymph node biopsy (SLNB) has become the preferred method of surgical
pathological nodal staging of early breast cancer by the end of the nineties. As the most …